Lytic cycle reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) can be initiated by transcription activation of the ORF50 immediate-early (IE) gene promoter (ORF50p). We provide evidence that KSHV virions stimulate transcription of ORF50p. Virion activation was resistant to UV inactivation and cycloheximide treatment. The virion-responsive element was mapped to core promoter region ؊150 to ؉ 1 relative to the ORF50 initiation codon. Electrophoretic mobility shift assays and chromatin immunoprecipitation suggest that KSHV virions indirectly alter the protein composition and chromatin modifications at ORF50p. These data suggest that KSHV virions possess an IE trans-inducing function similar to that observed in alpha-and betaherpesviruses.
Kaposi's sarcoma-associated herpesvirus (KSHV) (or human herpesvirus 8) is a human gammaherpesvirus associated with Kaposi's sarcoma (1, 6, 12) , pleural effusion lymphoma, and multicentric Castleman's disease (9, 40) . B lymphocytes are thought to be the primary reservoir for latent KSHV (8, 36, 37 ; reviewed in references 16, 18, and 39) , but viral DNA and transcripts can be detected in keratinocytes, endothelial cells, and epithelial cells in vivo and KSHV can infect these cells in vitro (2, 4, 5, 15, 19, 25, 26, 34, 45) . KSHV primary infections in vitro often result in abortive lytic replication followed by an unstable latency (15, 21, 25, 36) . The inability to sustain a lytic replicative cycle is a hallmark of human gammaherpesviruses, and the mechanisms limiting viral permissivity are not well understood.
Reactivation of KSHV latency can be initiated by various environmental and chemical triggers, including hypoxia (13, 23) , phorbol esters, and sodium butyrate (10, 14, 32, 33, 37, 46) . Additionally, superinfection with other viruses, including cytomegalovirus (CMV) and human immunodeficiency virus, can induce lytic cycle gene expression from latent KSHV (31, 44, 45) . All of these agents are thought to act, directly or indirectly, by stimulating transcription activation of the KSHV ORF50 immediate-early (IE) promoter. Ectopic expression of the ORF50 protein (RTA) induces lytic cycle gene expression and replication (20, 29, 42) . RTA can autostimulate ORF50p (14) through a mechanism that may involve interaction with several cellular DNA binding factors (22, 27, 38) . Nucleosome positioning and histone tail modifications can also influence ORF50p transcription activity (28) . Several other activities that activate and repress ORF50 have been identified (22, 23, 38, 46, 47) , and these may contribute to complex regulatory properties and the different activity levels in various cell types.
Immediate-early promoters from alpha-and betaherpesviruses can be activated by a virus-encoded virion factor (24) . To determine whether ORF50p was subject to KSHV virion-mediated transcription activation, we purified KSHV virions from BCBL1 cells induced with sodium butyrate and tetradecanoyl phorbol acetate (TPA). For comparison, we also purified Epstein-Barr virus (EBV) virions from D98/HR1 cells and mocktreated virions from uninfected DG75 cells treated with sodium butyrate and TPA. To produce KSHV virions, BCBL1 cells (0.5 ϫ 10 6 /ml) were induced with 1 mM sodium butyrate and 50 ng/ml TPA for 72 h. The cell-free medium was collected by two rounds of centrifugation at 1,600 ϫ g for 15 min and passaged through a 0.45-m filter. Virions were pelleted from the filtrate by centrifugation at 100,000 ϫ g for 1 h through 5 ml of a 5% sucrose cushion in a Beckman SW28 rotor. The virion pellets were resuspended in Dulbecco's modified Eagle's medium with 10% fetal bovine serum for infection or washed and resuspended in phosphate-buffered saline for Western blotting and colloidal blue staining (Invitrogen). Virions prepared from 10 9 cells were typically used for infection of 10 7 293 or BCBL1 cells, as indicated below.
The various virion preparations were analyzed by colloidal blue staining of sodium dodecyl sulfate-polyacrylamide gels (Fig. 1A) and by Western blotting with antibody specific for the tegument proteins ORF45 (Fig. 1B) and ORF50 (Fig. 1C) . As expected, ORF45 was detected in KSHV virions only, and ORF50 was detected only in BCBL1 cells and not virions (Fig.  1C) . We next assayed the ability of KSHV virions to stimulate ORF50p-Luc in transfected 293 cells (Fig. 1D) . KSHV has been shown to infect and initiate early lytic gene expression in 293 cells (4, 17, 49) . We found that KSHV virions specifically stimulated ORF50p-Luc by ϳ50-fold but did not activate the control pGL3 luciferase vector. In contrast, EBV or mocktreated virions did not activate ORF50p-Luc or pGL3. We also found that ORF50p (Ϫ290 to ϩ1) was stimulated ϳ20-fold by KSHV virions, suggesting that most of the responsive elements were within the first 290 nucleotides of the ORF50 ATG.
To determine if KSHV virion-induced activation of ORF50p was dependent upon virion proteins rather than viral-DNA-encoded proteins, we assayed the ability of UV-inactivated virus to stimulate ORF50p transcription (Fig. 2) . UV-irradiated KSHV virions were assayed for their ability to express viral RNA after infection of 293 cells ( Fig. 2A) . As expected, UV irradiation eliminated almost all ORF50 and LANA RNA expression after 293 cell infection ( Fig. 2A, left panel) . Reverse transcriptase PCR (RT-PCR) analysis was specific for RNA since elimination of reverse transcriptase eliminated all PCR amplification signals ( Fig. 2A, right panel) . UV-irradiated or untreated virions were assayed for their ability to stimulate ORF50p in transfected 293 cells (Fig. 2B) . We found that UV-irradiated virions stimulated ORF50p-Luc activity by ϳ10-fold, relative to ϳ18.5-fold for untreated virions. This slight decrease in transcription activation most likely reflects the effects of virus-encoded proteins, like RTA, that can weakly autoactivate ORF50p (14, 38) . UV-irradiated or untreated virions were then assayed for their ability to stimulate endogenous ORF50p in latently infected BCBL1 cells (Fig. 2C) . Mock-treated, KSHV, and UV-inactivated KSHV virions were incubated with BCBL1 cells and assayed by RT-PCR for their ability to alter ORF50 or LANA mRNA levels. We found that KSHV and UV-irradiated virions stimulated ORF50 mRNA significantly above background levels (Fig. 2C) . In contrast, LANA mRNA levels did not increase significantly when BCBL1 cells were incubated with KSHV and UV-irradiated KSHV virions. None of these treatments had significant effects on cellular GAPDH (glyceraldehyde-3-phosphate dehydrogenase) control levels, and all amplified products were dependent upon the addition of reverse transcriptase, indicating that RNA, and not DNA, was being amplified. Essentially identical results were observed when cRNA levels were quantitated by real-time PCR (Fig. 2D ). To determine if protein synthesis was required for virion activation of ORF50 transcription, cycloheximide was added to BCBL1 cells 4 h prior to incubation with mock-treated, KSHV, or UV-inactivated KSHV virions ( Fig. 2E and F) . We found that ORF50 mRNA was weakly (ϳ1.5-fold) stimulated by KSHV and UV-inactivated KSHV in the presence of cycloheximide (Fig. 2E ). This weak activation may reflect a requirement for some protein synthesis or may reflect the cytotoxicity of cycloheximide treatment on BCBL1 cells. The complex effects of cycloheximide were further revealed by the reduction in mRNA levels for K12 and PAN, two viral genes responsive to RTA transcription activation (11) . To eliminate the complex effects of cycloheximide on cellular ␤-actin, we compared ORF50 and K12 mRNA levels relative to KSHV-encoded PAN mRNA levels (Fig. 2F) . Using this analysis, we found that UV-inactivated KSHV stimulated ORF50 mRNA approximately twofold but had no effect on K12 mRNA (Fig. 2F) . Furthermore, cycloheximide treatment did not eliminate the ability of KSHV to stimulate ORF50p-luciferase mRNA in 293 cells (Fig. 2G ). These findings suggest that a virion component specifically activates ORF50 relative to other Rta-responsive genes, like K12 and PAN.
The target specificity of KSHV virion transcription activation was determined by comparing the responses of several different viral promoters (Fig. 3A) . 293 cells were transfected with luciferase plasmids containing the EBV BZLF1 promoter (EBV-Zp), the KSHV K8-IE or delayed early (K8-DE) promoter, or ORF50p. We found that ORF50p was most responsive to KSHV virions, but weaker activation could also be detected for EBV-Zp and K8-IE.
Deletion mutagenesis of ORF50p indicated that sequences to Ϫ1038 contributed to KSHV virion activation (Fig. 3B) . Deletion of 5Ј sequences to Ϫ157 provided approximately ninefold activation in response to KSHV virions, but further deletion to Ϫ100 eliminated any significant activation to levels below those of pGL3 alone. These results suggest that promoter sequences between Ϫ157 to ϩ 1 relative to the ATG initiation codon provide a minimal response element for activation by KSHV virions.
Substitution mutagenesis of ORF50p revealed that several regions contribute to virion-mediated transcription activation. In particular, we found that mutagenesis of sequences at po- sitions Ϫ84 and Ϫ98 reduced the virion response to background levels. Substitutions at Ϫ148, Ϫ128, Ϫ114, and Ϫ93 reduced virion activation almost twofold, suggesting that multiple regions of the ORF50 minimal promoter constitute the KSHV virion response element (Fig. 3C) .
The above results suggest that KSHV virions may alter some general activity that associates with the ORF50 immediateearly gene promoter. To examine this possibility, nuclear extracts from mock-and KSHV virion-infected 293 cells were assayed for ORF50 DNA binding activity in electrophoretic mobility shift assays (EMSA) (Fig. 4A) . Mock-infected 293 cells contained at least three major ORF50p DNA binding activities (Fig. 4A, lane 2) . The fastest-migrating activity was most likely not specific for ORF50p since a species with a similar mobility was detected in ORF73 DNA binding (Fig.  4A, lane 5) . Interestingly, this nonspecific binding activity disappeared in KSHV-infected cell nuclear extracts (Fig. 4A,  lanes 3 and 6) . KSHV infection did not alter the slower-migrating and more-specific ORF50p DNA binding activities (Fig. 4A, lane 3) . These findings suggest that KSHV infection eliminates a nonspecific DNA binding activity that strongly associates with ORF50p and perhaps other viral promoters. KSHV infection enhanced histone H3 and H4 acetylation on ORF50p (Fig. 4B, top panel) but did not have a similar effect on the cellular GAPDH promoter. This increased histone acetylation correlated with transcription activation (Fig. 1 to 4) . A similar level of histone hyperacetylation at ORF50p was observed when cells were treated with sodium butyrate (28; data not shown). These findings indicate that KSHV infection increases histone acetylation of nucleosomes associated with ORF50p.
We have shown here that KSHV virions induced transcription activation of ORF50p in transfected 293 cells ( Fig. 1 and  2 ) and from endogenous viral genomes in latently infected PEL cells (Fig. 2C and D) . The minimal ORF50p nucleotide sequence required for KSHV virion activation was mapped to a region within Ϫ157 to ϩ 1 of the initiation ATG, and several substitution mutations within this region eliminated virion activation (Fig. 3) . KSHV virions induced changes in the nucleoprotein complex on ORF50p DNA in EMSA and stimulated histone H3 and H4 acetylation on transfected ORF50p plasmid DNA (Fig. 4) . Together, these results suggest that KSHV virions possess an activity that alters cellular protein interactions with ORF50p. EMSA did not detect a novel protein association with ORF50p, suggesting that a KSHV-encoded VP16-like activity does not assemble at ORF50p. Alternatively, KSHV is known to bind to cell surface integrins and initiate phosphoinositide 3-kinase-mediated signal transduc- , (Ϫ290 to ϩ1), (Ϫ157 to ϩ1), (Ϫ100 to ϩ1), or pGL3 were compared in luciferase activity assays in 293 cells incubated with mock-treated or KSHV virions. C) Substitution mutations in ORF50p (Ϫ157 to ϩ1) were generated at positions Ϫ148, Ϫ135, Ϫ128, Ϫ120, Ϫ114, Ϫ98, Ϫ93, and Ϫ84 and were assayed for luciferase activity in 293 cells after incubation with mock-treated or KSHV virions. RLU, relative light units. tion (3, 35) . Initiation of integrin signaling by KSHV stimulates phosphoinositide 3-kinase, and protein kinase C pathways may have indirect effects on stress kinase pathways and indirectly stimulate ORF50p transcription (35) . Other herpesviruses encode virion proteins that can affect viral gene expression and influence lytic cycle progression. The herpes simplex virus (HSV) virion protein VP16 can assemble with cellular factors on the HSV immediate-early promoter TAATGARAT sites to activate lytic cycle gene expression (reviewed in reference 48). HSV virion protein 22 (VP22) can inhibit nucleosome assembly that blocks lytic cycle progression (43) . The CMV UL82-encoded virion protein pp71 can activate CMV major immediate-early promoter-dependent transcription and is required for lytic replication (7, 30, 41) . Although KSHV does not have an obvious homologue of these virion regulatory proteins, our data suggest that KSHV virions possess a trans-inducing function that is similar in principle to those characterized for HSV and CMV.
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